Showing 12 out of 2273 items
- There are many potential medicines in development for the prevention and treatment of COVID-19. One group of potential therapies is called monoclonal antibodies.
- Scientists at Regeneron Pharmaceuticals have developed two antibodies that attack different parts of SARS-CoV-2. The combination of antibodies is called Regen-CoV.
- Regen-CoV is the brand name of a combination of two antibodies that attack SARS-CoV-2. The antibodies are as follows:
- Regen-CoV is the brand name of a combination of two antibodies that attack SARS-CoV-2. The antibodies are as follows:
- AT-527 is a nucleoside analogue that is being developed as a potential treatment for COVID-19. The drug is taken orally. This drug is an analogue of a naturally occurring substance called guanosine.…
- Adenoviruses are a large family of viruses that can cause a range of illness in people and animals. In people, these viruses can cause relatively mild illness such as colds and pink eye or more…
- Clinical trials of the Janssen COVID-19 vaccine (in some parts of the world this is called the Johnson & Johnson COVID-19 vaccine) have found that it is generally safe.
- Observational studies have generally reported similar results in HIV-positive and HIV-negative people who have been hospitalized with COVID-19.
- This living document provides the latest information on COVID-19 vaccination third doses for people living with HIV across Canada.
- This report is a general outline of the “safe supply” concept, of what safe supply is, and the role of safe supply in drug policy.
- Housing Overdose Prevention Sites (HOPS) opened as part of the provincial response to the opioid overdose (OD) emergency in December 2016 as directed by the British Columbia Minister of Health.
